NCT07555938
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07555938
Title Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma (CEVOLUTION)
Acronym CEVOLUTION
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope National Medical Center RECRUITING Duarte California 91010-3012 United States Details
City of Hope - Lennar Foundation Cancer Center RECRUITING Irvine California 92618 United States Details
Emory University Hospital Midtown RECRUITING Atlanta Georgia 30308 United States Details
Novant Health Cancer Institute RECRUITING Charlotte North Carolina 28204 United States Details
Forsythe Memorial Hospital Inc., dba Novant Health Oncology Specialists RECRUITING Winston-Salem North Carolina 27103 United States Details
TriHealth Cancer and Blood Institute RECRUITING Cincinnati Ohio 45220 United States Details
Nagoya City University Hospital RECRUITING Aichi 467-8602 Japan Details
University Hospital Kyoto Prefectural University of Medicine RECRUITING Kyoto 602-8566 Japan Details
The Cancer Institute Hospital of JFCR RECRUITING Tokyo 135-8550 Japan Details
Yamagata University Hospital RECRUITING Yamagata 990-9585 Japan Details
Auxilio Mutuo Cancer Center RECRUITING San Juan 917 Puerto Rico Details
Chonnam National University Hwasun Hospital RECRUITING Jeollanam-do 58128 South Korea Details
Seoul National University Hospital RECRUITING Seoul 03080 South Korea Details
Asan Medical Center RECRUITING Seoul 05505 South Korea Details
Seoul St Mary's Hospital RECRUITING Seoul 06591 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field